NIH-funded research NIH-funded research

Exploring how colored light can reduce chronic pain

Official title: Neural Mechanisms of Colored Light Driven Analgeisa

Funded at Univ of North Carolina Chapel Hill · NIH-11032610 · Data updated 2026-11-12

This study is looking at how colored light therapy might help people with chronic pain conditions like fibromyalgia and chronic low back pain by exploring how light affects the brain's pain pathways.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 19, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$4,572,599
NIH project number1RM1NS140200-01
Project IDNIH-11032610 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from chronic musculoskeletal pain, including conditions like fibromyalgia and chronic low back pain.

Less likely to help

Patients with acute pain conditions or those who do not respond to light therapy may not benefit from this research.

What this research studies

This research investigates the potential of light therapy, specifically colored light, as a non-addictive treatment for chronic musculoskeletal pain (cMSP) conditions like fibromyalgia and chronic low back pain. By delivering light to the retina, the study aims to understand the neural mechanisms that enable this therapy to alleviate pain. Researchers will explore how specific visual pathways and color-sensitive cells in the retina interact with pain pathways in the brain. The goal is to unlock the therapeutic potential of light by identifying the specific neural circuits involved in pain modulation.

Why it matters

Potential benefit: If successful, this research could provide a new, non-pharmacologic treatment option for patients suffering from chronic pain, reducing reliance on opioids.

How similar studies have gone: Previous research has shown promising results for light therapy in pain management, suggesting that this approach may be effective, although the specific mechanisms remain largely unexplored.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Mauck, Matthew Christopher — Univ of North Carolina Chapel Hill
  • Study coordinator: Mauck, Matthew Christopher

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.